Similar findings that higher pre-treatment mast cell infiltration is significantly associated with poor responses to pre-surgical chemotherapy in an aggressive form of localized breast cancer42, and higher mast cell tumor infiltration predicts poor responses to anti-PD-1 ICB in melanoma39. This evidence concerns the gene PDCD1 and mast cell neoplasm.